The importance of randomised vs non-randomised trials – Authors' reply
- 1 August 2019
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 394 (10199), 635
- https://doi.org/10.1016/s0140-6736(19)31111-0
Abstract
No abstract availableFunding Information
- AstraZeneca
- University of Glasgow
- Sanofi
- Bayer
- Novo Nordisk
- Boehringer Ingelheim
- GlaxoSmithKline
- Janssen Pharmaceuticals
- Johnson and Johnson
- Merck Sharp and Dohme
- Pfizer
- Kowa Company
- Novartis
- Bristol-Myers Squibb
- Eli Lilly and Company
- Abbott Laboratories
- Amgen
- Merck
This publication has 1 reference indexed in Scilit: